Role of microRNAs in T cell development
microRNA 在 T 细胞发育中的作用
基本信息
- 批准号:8349336
- 负责人:
- 金额:$ 39.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:ApoptosisApoptoticDevelopmentDicer EnzymeEquilibriumEukaryotaFunctional RNAGene ExpressionGenerationsGenesGoalsKnock-outMessenger RNAMicroRNAsMusPost-Transcriptional RegulationProtein BiosynthesisRNARNA InterferenceRoleStagingT-Cell DevelopmentT-LymphocyteThymocyte DevelopmentThymus Glandhuman DICER1 proteinprotein expressionthymocyte
项目摘要
RNA intererence is a one of the major mechanisms of post-transcriptional regulation of protein expression in eukaryotes. This mechanism is using small non-coding RNAs (miRNAs) to destabilize specific mRNAs and to suppress protein synthesis. Many miRNAs genes are expressed in T cells during development in a thymus. However the function of RNAi in T cell development remains unclear. To investigate the role of RNAi during thymic development we generated conditional knockout of the enzyme Dicer in the mouse, which is critical for miRNA generation. We observed a dramatic reduction in the number of thymocytes in Dicer-deficient mice and we determined that the reason is a block of progression from DN to DP stage during thymocyte development. Importantly, we found an alteration in the balance between pro- and anti-apoptotic factors in RNAi deficient DP thymocytes. We also observed that RNAi-deficient thymocytes are rapidly undergoing apoptosis. Most importantly, we have also identified the precise gene whose expression is downregulated by microRNAs to permit survival of developing T cells in the thymus.
RNA干扰是真核生物蛋白质表达转录后调控的主要机制之一。这种机制是使用小的非编码RNA(miRNA)来破坏特定mRNA的稳定性并抑制蛋白质合成。许多miRNA基因在胸腺发育期间在T细胞中表达。然而,RNAi在T细胞发育中的功能仍不清楚。为了研究RNAi在胸腺发育过程中的作用,我们在小鼠中产生了对miRNA产生至关重要的酶Dicer的条件性敲除。我们观察到Dicer缺陷小鼠的胸腺细胞数量急剧减少,我们确定其原因是胸腺细胞发育期间从DN到DP阶段的进展受阻。重要的是,我们发现了RNAi缺陷DP胸腺细胞中促凋亡因子和抗凋亡因子之间平衡的改变。我们还观察到RNAi缺陷的胸腺细胞正在迅速发生凋亡。最重要的是,我们还确定了精确的基因,其表达被microRNA下调,以允许发育中的T细胞在胸腺中存活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alfred Singer其他文献
Alfred Singer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alfred Singer', 18)}}的其他基金
T cell receptor regulation of cytokine signaling
T 细胞受体对细胞因子信号传导的调节
- 批准号:
10702478 - 财政年份:
- 资助金额:
$ 39.09万 - 项目类别:
相似海外基金
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
- 批准号:
10862033 - 财政年份:2023
- 资助金额:
$ 39.09万 - 项目类别:
Mechanisms of non-apoptotic caspase-3 regulation of auditory brainstem development
非凋亡 caspase-3 调节听觉脑干发育的机制
- 批准号:
10335160 - 财政年份:2021
- 资助金额:
$ 39.09万 - 项目类别:
Development of new anti-cancer drug with anti-apoptotic protein MCL-1 selective inhibitory activity
具有抗凋亡蛋白MCL-1选择性抑制活性的新型抗癌药物的开发
- 批准号:
20K06977 - 财政年份:2020
- 资助金额:
$ 39.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Apoptotic mechanism and development of rescue method in bovine GV-stage oocytes after cryopreservation
牛GV期卵母细胞冻存后的凋亡机制及拯救方法的进展
- 批准号:
20K06379 - 财政年份:2020
- 资助金额:
$ 39.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Osteoporosis Treatment Nano-vehicles via Apoptotic Cell Inspired Materials
通过凋亡细胞启发材料开发骨质疏松症治疗纳米载体
- 批准号:
19K19045 - 财政年份:2019
- 资助金额:
$ 39.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Aiming at the development of new therapeutic agents for oral cancer via anti-apoptotic function by Keratin17
旨在通过 Keratin17 的抗凋亡功能开发口腔癌新治疗剂
- 批准号:
17H06947 - 财政年份:2017
- 资助金额:
$ 39.09万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of novel treatment strategies for adult T-cell leukemia/lymphoma by targeting anti-apoptotic proteins.
通过靶向抗凋亡蛋白开发成人 T 细胞白血病/淋巴瘤的新治疗策略。
- 批准号:
17K09933 - 财政年份:2017
- 资助金额:
$ 39.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of apoptotic cell membrane mimetic polymers for anti-inflammatory therapy
用于抗炎治疗的凋亡细胞膜模拟聚合物的开发
- 批准号:
16K01402 - 财政年份:2016
- 资助金额:
$ 39.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering a gene regulatory network that governs the apoptotic cell fate during animal development.
破译动物发育过程中控制细胞凋亡命运的基因调控网络。
- 批准号:
454301-2014 - 财政年份:2015
- 资助金额:
$ 39.09万 - 项目类别:
Postgraduate Scholarships - Doctoral
Role of Histon H2A deubiquitinase 2A-DUB/Mysm1 in lymphoid development and interaction with p53-mediated apoptotic programs
组蛋白 H2A 去泛素酶 2A-DUB/Mysm1 在淋巴发育中的作用以及与 p53 介导的细胞凋亡程序的相互作用
- 批准号:
266397124 - 财政年份:2014
- 资助金额:
$ 39.09万 - 项目类别:
Research Grants














{{item.name}}会员




